{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:19:53Z","timestamp":1788286793391,"version":"build-2803163510"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Proteinuria is reported in 68%-71% of dogs with spontaneous hypercortisolism (HC). The long-term effect of trilostane on HC-associated proteinuria remains poorly documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>To evaluate the efficacy of trilostane on proteinuria in dogs with HC and identify potential clinical, anamnestic, and analytical differences between responders and nonresponders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective longitudinal cohort study including dogs with proteinuric HC treated exclusively with trilostane. Clinical history and laboratory data at diagnosis (T0) were retrieved. When available, urine protein-to-creatinine ratio (UPC), disease clinical score (DCS), blood pressure (BP), and daily trilostane dosage (TD) were recorded at 30, 90, 180, and 365\u00a0days (T30, T90, T180, and T365) after treatment initiation. Dogs achieving a\u00a0\u2265\u00a050% UPC reduction or a final UPC\u00a0&amp;lt;\u00a00.5 were defined as \u201cresponders.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred sixty dogs met inclusion criteria: 89% had pituitary-dependent HC and 10% adrenal-dependent HC. At diagnosis, 64% were proteinuric. A significant UPC reduction over time occurred (P\u00a0=\u00a0.0005; F(4,153.9)\u00a0=\u00a05.26), with statistically significant decreases at T90 (P\u00a0=\u00a0.020; difference, 1.093; 95% CI, 0.115-2.071), T180 (P\u00a0=\u00a0.031; difference, 1.122; 95% CI, 0.064-2.181), and T365 (P\u00a0=\u00a0.002; difference, 1.599; 95% CI, 0.436-2.761) compared to baseline. At the last follow-up, 76 dogs were evaluable; 48% were responders and had lower median DCS, BP, and TD (P\u00a0=\u00a0.029, P\u00a0=\u00a0.025, and P\u00a0=\u00a0.048, respectively) than nonresponders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Trilostane induces a significant and sustained reduction in proteinuria in some dogs with spontaneous HC, evident from 3 months of treatment. Responders exhibit better control of hypertension and clinical signs despite lower TD. Nonresponders account for 52% of proteinuric dogs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jvimsj\/aalag189","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:11:37Z","timestamp":1788286297000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of trilostane treatment on proteinuria secondary to spontaneous hypercortisolism in dogs"],"prefix":"10.1093","volume":"40","author":[{"given":"Filippo","family":"Tagliasacchi","sequence":"first","affiliation":[{"name":"Department of Veterinary Medical Science, University of Bologna , Ozzano dell'Emilia, Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Fracassi","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Science, University of Bologna , Ozzano dell'Emilia, Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Poli","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Science, University of Bologna , Ozzano dell'Emilia, Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Dalla","family":"Tomba","sequence":"additional","affiliation":[{"name":"Ospedale Veterinario San Francesco , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Golinelli","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Science, University of Bologna , Ozzano dell'Emilia, Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Tardo","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Science, University of Bologna , Ozzano dell'Emilia, Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Baldo","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Science, University of Bologna , Ozzano dell'Emilia, Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026090114113382500_ref1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/vetsci12080761","article-title":"Agreeing language in veterinary endocrinology (ALIVE): Cushing\u2019s syndrome and hypoadrenocorticism\u2014a modified Delphi-method-based system to create consensus definitions","volume":"12","author":"Niessen","year":"2025","journal-title":"Vet Sci"},{"key":"2026090114113382500_ref2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1748-5827.2002.tb00019.x","article-title":"Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs","volume":"43","author":"Goy-Thollot","year":"2002","journal-title":"J Small Anim Pract"},{"key":"2026090114113382500_ref3","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.2460\/javma.1996.209.10.1724","article-title":"Systemic arterial blood pressure and urine protein-creatinine ratio in dogs with hyperadrenocorticism","volume":"209","author":"Ortega","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"2026090114113382500_ref4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1939-1676.2012.00915.x","article-title":"Long-term follow-up of renal function in dogs after treatment for ACTH-dependent hyperadrenocorticism","volume":"26","author":"Smets","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11259-008-9133-z","article-title":"Ratio of urinary protein to creatinine and albumin to creatinine in dogs with diabetes mellitus and hyperadrenocorticism","volume":"32","author":"Mazzi","year":"2008","journal-title":"Vet Res Commun"},{"key":"2026090114113382500_ref6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1751-0147-52-61","article-title":"Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism","volume":"52","author":"Lien","year":"2010","journal-title":"Acta Vet Scand"},{"key":"2026090114113382500_ref7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2460\/javma.1998.212.03.369","article-title":"Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism","volume":"212","author":"Hurley","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"2026090114113382500_ref8","doi-asserted-by":"publisher","first-page":"3814034","DOI":"10.1155\/2016\/3814034","article-title":"Association of renal resistive index, renal pulsatility index, systemic hypertension, and albuminuria with survival in dogs with pituitary-dependent hyperadrenocorticism","volume":"2016","author":"Chen","year":"2016","journal-title":"Int J Endocrinol"},{"key":"2026090114113382500_ref9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1939-1676.1997.tb00086.x","article-title":"Effects of glucocorticoid therapy on urine protein-to-creatinine ratios and renal morphology in dogs","volume":"11","author":"Waters","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jsap.70034","article-title":"Electrophoretic patterns of proteinuria in dogs with Cushing\u2019s syndrome","volume":"67","author":"Milenkovic","year":"2025","journal-title":"J Small Anim Pract"},{"key":"2026090114113382500_ref11","doi-asserted-by":"publisher","first-page":"106108","DOI":"10.1016\/j.tvjl.2024.106108","article-title":"Description of serum symmetric dimethylarginine concentration and of urinary SDS-AGE pattern in dogs with ACTH dependent hyperadrenocorticism","volume":"305","author":"Menard","year":"2024","journal-title":"Vet J"},{"key":"2026090114113382500_ref12","first-page":"397","article-title":"Update on the use of trilostane in dogs","volume":"59","author":"Lemetayer","year":"2018","journal-title":"Can Vet J"},{"key":"2026090114113382500_ref13","doi-asserted-by":"publisher","first-page":"e1630","DOI":"10.1002\/vetr.1630","article-title":"Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane","volume":"191","author":"Garc\u00eda San Jos\u00e9","year":"2022","journal-title":"Vet Rec"},{"key":"2026090114113382500_ref14","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/jvim.12192","article-title":"Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal)","volume":"27","author":"Behrend","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/B978-1-4557-4456-5.00010-9","volume-title":"Canine and Feline Endocrinology","author":"Behrend","year":"2015","edition":"4"},{"key":"2026090114113382500_ref16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/jvim.16620","article-title":"Clinical features of muscle stiffness in 37 dogs with concurrent naturally occurring hypercortisolism","volume":"37","author":"Golinelli","year":"2023","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref17","author":"International Renal Interest Society (IRIS)"},{"key":"2026090114113382500_ref18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/jvim.16378","article-title":"Prevalence of positive urine culture in the presence of inactive urine sediment in 1,049 urine samples from dogs","volume":"36","author":"Strachan","year":"2022","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref19","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jvim.15331","article-title":"ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"32","author":"Acierno","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref20","author":"International Renal Interest Society (IRIS)"},{"key":"2026090114113382500_ref21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1590\/s0100-736x2017000700014","article-title":"Urine protein electrophoresis study in dogs with pituitary-dependent hyperadrenocorticism during therapy with trilostane","volume":"37","author":"Caragelasco","year":"2017","journal-title":"Pesq Vet Bras"},{"key":"2026090114113382500_ref22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1590\/S0100-736X2013001100012","article-title":"Evaluation of albuminuria and electrophoresis of urinary proteins from dogs with hyperadrenocorticism and relation with systemic arterial pressure","volume":"33","author":"Cavalcante","year":"2013","journal-title":"Pesq Vet Bras"},{"key":"2026090114113382500_ref23","doi-asserted-by":"publisher","first-page":"106146","DOI":"10.1016\/j.tvjl.2024.106146","article-title":"Phosphocalcic metabolism and its potential association with biomarkers of kidney disease in dogs with spontaneous hyperadrenocorticism","volume":"305","author":"Da Riz","year":"2024","journal-title":"Vet J"},{"key":"2026090114113382500_ref24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/vr.159.9.277","article-title":"Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs","volume":"159","author":"Bell","year":"2006","journal-title":"Vet Rec"},{"key":"2026090114113382500_ref25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","article-title":"Cushing\u2019s syndrome","volume":"37","author":"Pivonello","year":"2008","journal-title":"Endocr Metab Clin"},{"key":"2026090114113382500_ref26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1530\/eje.1.02040","article-title":"Glomerular filtration rate in patients with Cushing\u2019s disease: a matched case-control study","volume":"153","author":"Haentjens","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2026090114113382500_ref27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1939-1676.1997.tb00086.x","article-title":"Effects of glucocorticoid therapy on urine protein-to-creatinine ratios and renal morphology in dogs","volume":"11","author":"","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1939-1676.2007.0039.x","article-title":"Effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs","volume":"22","author":"Schellenberg","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref29","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1939-1676.2012.00956.x","article-title":"Trilostane dose versus body weight in the treatment of naturally occurring pituitary-dependent hyperadrenocorticism in dogs","volume":"26","author":"Feldman","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygcen.2010.07.004","article-title":"Cushing\u2019s syndrome, glucocorticoids and the kidney","volume":"169","author":"Smets","year":"2010","journal-title":"Gen Comp Endocrinol"},{"key":"2026090114113382500_ref31","doi-asserted-by":"publisher","first-page":"106108","DOI":"10.1016\/j.tvjl.2024.106108","article-title":"Description of serum symmetric dimethylarginine concentration and urinary SDS-AGE pattern in dogs with ACTH-dependent hyperadrenocorticism","volume":"305","author":"Benchekroun","year":"2024","journal-title":"Vet J"},{"key":"2026090114113382500_ref32","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/jvim.15322","article-title":"Factors associated with survival in dogs with chronic kidney disease","volume":"32","author":"Rudinsky","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2460\/javma.2003.222.322","article-title":"Association between initial systolic blood pressure and risk of developing a uremic crisis or of dying in dogs with chronic renal failure","volume":"222","author":"Jacob","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"2026090114113382500_ref34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2460\/javma.2005.226.393","article-title":"Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure","volume":"226","author":"Jacob","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026090114113382500_ref35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/vr.162.5.141","article-title":"Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases","volume":"162","author":"Wehner","year":"2008","journal-title":"Vet Rec"},{"key":"2026090114113382500_ref36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/vr.163.20.592","article-title":"Increased renal vascular resistance in dogs with hyperadrenocorticism assessed by Doppler ultrasonography","volume":"163","author":"Novellas","year":"2008","journal-title":"Vet Rec"},{"key":"2026090114113382500_ref37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/vr.105159","article-title":"Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England","volume":"186","author":"Schofield","year":"2020","journal-title":"Vet Rec"},{"key":"2026090114113382500_ref38","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/jvim.12286","article-title":"Longitudinal prevalence of hypertension, proteinuria, and retinopathy in dogs with spontaneous diabetes mellitus","volume":"28","author":"Herring","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026090114113382500_ref39","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2460\/javma.1998.213.06.822","article-title":"Systemic hypertension and proteinuria in dogs with diabetes mellitus","volume":"213","author":"Struble","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"2026090114113382500_ref40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1939-165X.2009.00167.x","article-title":"The use of pooled vs serial urine samples to measure urine protein:creatinine ratios","volume":"39","author":"LeVine","year":"2010","journal-title":"Vet Clin Pathol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/5\/aalag189\/70895380\/aalag189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/5\/aalag189\/70895380\/aalag189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:11:38Z","timestamp":1788286298000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1093\/jvimsj\/aalag189\/8778687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jvimsj\/aalag189","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"aalag189"}}